I'm participating in a clinical trial called "A Phase II Study of the Selective BRAF Kinase Inhibitor GSK2118436 in Subjects With Advanced Non-small Cell Lung Cancer and BRAF Mutations" and am hoping to link up with others enrolled in this trial. Only forty are to be enrolled worldwide so it's kind of a long shot.
Anybody else out there?
To avoid confusion, here is the address for the ClinicalTrials.gov page on this trial. http://clinicaltrials.gov/ct2/show/NCT0 ... cer&rank=1
Only patients with the BRAF mutation are eligible.